(Reuters) -Eli Lilly’s treatment for early Alzheimer’s is expected to be blocked for use by Britain’s National Health Service (NHS), the Telegraph reported on Friday. The drug donanemab would be rejected by the National Institute for Health and Care Excellence(NICE), which decides what drugs are available on the NHS, the newspaper reported citing insiders. The…
By Phil Stewart AMMAN (Reuters) – The top U.S. general began an unannounced visit to the Middle East on Saturday to discuss ways to avoid any new escalation in tensions that could spiral into a broader conflict, as the region braces for a threatened Iranian attack against Israel. Air Force General C.Q. Brown, chairman of…
(Reuters) -Microsoft said on Friday it would hold a summit in September on improving cybersecurity systems, after a faulty update from CrowdStrike caused a global IT outage last month. The conference marks the first big step by Microsoft to address the issues that affected nearly 8.5 million Windows devices on July 19, disrupting operations across…
By Leika Kihara JACKSON HOLE, Wyoming (Reuters) – The U.S. Federal Reserve’s dovish shift will likely give the Bank of Japan some respite in its battle to tame a weak yen, but could complicate its efforts to raise interest rates if the two central banks’ diverging policy paths keep markets jittery. At an annual symposium…
(Reuters) – Elon Musk’s brain technology startup Neuralink said its implant, designed to allow paralyzed patients to use digital devices by thinking alone, is working well in a second trial patient. The company said the patient, identified as Alex, did not face issues of “thread retraction”, unlike Noland Arbaugh, Neuralink’s first patient who received the…
By Dietrich Knauth and Mike Spector NEW YORK (Reuters) – Johnson & Johnson said on Friday it is negotiating with plaintiffs’ lawyers who have opposed the company’s proposed settlement of lawsuits alleging its baby powder and other talc products caused cancer, seeking to eliminate holdouts to the deal. J&J has announced plans to finalize a…
By Jody Godoy (Reuters) – An appeals court in Washington, D.C. revived the district’s lawsuit against Amazon.com Inc on Thursday, saying it plausibly claimed the online retailer’s pricing policies illegally stifle competition. The District of Columbia Court of Appeals reversed a ruling that had dismissed the lawsuit, which accuses Amazon of harming competition through restrictions…
By Milana Vinn and Anirban Sen NEW YORK (Reuters) -Evolent Health is in talks with private equity firms and healthcare services providers for a potential sale, in a process that kicked off after it received takeover interest, people familiar with the matter said on Thursday. Private equity firms TPG, CD&R and KKR are among the…
By Siddharth Cavale NEW YORK (Reuters) – Walmart’s stake in Chinese e-commerce firm JD.com was once central to its China strategy. Now it is tearing up that playbook by unloading its entire $3.74 billion stake in one of China’s biggest online retailers, in another example of the volatile nature of its relationship with China. The unshackling…
By Ananya Mariam Rajesh, Siddharth Cavale (Reuters) -Target raised its full-year profit forecast on Wednesday and reported its first increase in quarterly comparable sales in over a year, driven by price cuts that attracted more shoppers to its stores. Target’s results reflect a similar strategy employed by Walmart and other retailers looking to attract increasingly…
